Physician
Joyal, Thomas
Joyal, Thomas was paid $410K by Medicaid between Feb 2019 and Sep 2024, across 15 billing codes. Its largest line is 87426, Infectious agent antigen detection, SARS-CoV-2 (COVID-19) — 34% of everything it billed.
33Billing provider infoJOYAL, THOMAS
MIAMI, FL 33136
MIAMI, FL 33136
33aNPI1891059846assigned 06/25/2012
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$410K
24GClaims14,009
24DCodes billed15
24AFirst – last monthFeb 2019 – Sep 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Florida
Rank by total paid#32 of 207
Median peer was paid$39K
This provider vs. median10×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 252 | $12K | |
| 2020 | 248 | $9K | |
| 2021 | 1,560 | $56K | |
| 2022 | 4,453 | $137K | |
| 2023 | 4,411 | $122K | |
| 2024incomplete | 3,085 | $74K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 34% | 3,755 | 3,491 | $139K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 19% | 2,090 | 1,889 | $79K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 10% | 728 | 574 | $42K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 9.4% | 1,882 | 1,121 | $39K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 9.4% | 1,865 | 1,117 | $39K |
| 88142 | 5.7% | 1,239 | 1,211 | $23K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 4.3% | 873 | 491 | $18K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 2.6% | 496 | 304 | $11K |
| 88141 | 2.5% | 388 | 381 | $10K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.1% | 297 | 291 | $4K |
| 87807 | 1.1% | 339 | 335 | $4K | |
| 87631 | <1% | 14 | 12 | $2K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.